Literature DB >> 2407782

Analysis of thymic stromal cell subpopulations grown in vitro on extracellular matrix in defined medium. II. Cytokine activities in murine thymic epithelial and mesenchymal cell culture supernatants.

I Eshel1, N Savion, J Shoham.   

Abstract

Two morphologically distinct primary cultures of murine thymic stroma were established and found to be of epithelial (MTEC) and mesenchymal (MTMC) origin. These cultures were generated by selective conditions of tissue disruption and were maintained on extracellular matrix in defined medium. Culture supernatants (CS) from these cultures (EC-CS and MC-CS respectively), were tested for cytokine production and for effects on thymocyte maturation. Both supernatants displayed the activities of IL-3 and of granulocyte/macrophage-CSF and not of IL-1, -2, -4, or IFN. In addition they were found to be mitogenic to murine thymocytes in a "spontaneous" [3H]TdR incorporation assay. The two supernatants differed, however, in their effect on Con A stimulation. EC-CS had a strong enhancing effect, both when used for preincubation (18 h) before Con A stimulation or when present simultaneously with it. MC-CS had a small inconsistent effect under these conditions. Also EC-CS enhanced IL-2 and IL-3 production by thymocytes. The responsive thymocyte subpopulation was the one that does not bind peanut agglutinin. CS of an established thymic epithelial cell line displayed only part of these activities at a considerably lower level. CS from primary kidney cell culture was completely devoid of activity. The results suggest that primary thymic stromal cell cultures, cultivated under the defined conditions described here, may better preserve physiologic secretory activities, and probably also other cell functions, compared with established cell lines. Furthermore, the results are compatible with the hypothesis that the soluble factors, secreted by thymic stromal cells, are active on either very early or late stages of thymic differentiation, whereas the main intrathymic stages of differentiation are conceivable dependent primarily on direct contact with stromal cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2407782

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Analysis of thymic stromal cell subpopulations grown in vitro on extracellular matrix in defined medium. III. Growth conditions of human thymic epithelial cells and immunomodulatory activities in their culture supernatant.

Authors:  L Schreiber; I Eshel; A Meilin; Y Sharabi; J Shoham
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

2.  DNA strand breaks and death of thymocytes induced by N-methyl-N-nitrosourea.

Authors:  T Ogiu; H Fukami; M Nishimura
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

3.  Immunohistochemical and ultrastructural evidence for myelopoiesis in the scid/scid mouse thymus.

Authors:  M D Kendall; D P Lane; U Schumacher
Journal:  Histochem J       Date:  1999-10

4.  IL-3 and IL-4 affect thymocyte differentiation in organ culture.

Authors:  P M Wood; R K Jordan; A L Givan; C G Brooks
Journal:  Immunology       Date:  1990-09       Impact factor: 7.397

5.  Analysis of thymic stromal cell subpopulations grown in vitro on extracellular matrix in defined medium. IV. Cytokines secreted by human thymic epithelial cells in culture and their activities on murine thymocytes and bone marrow cells.

Authors:  A Meilin; J Shoham; Y Sharabi
Journal:  Immunology       Date:  1992-10       Impact factor: 7.397

6.  Thymus involution induced by mouse hepatitis virus A59 in BALB/c mice.

Authors:  C Godfraind; K V Holmes; J P Coutelier
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

7.  Origin of germ cells and formation of new primary follicles in adult human ovaries.

Authors:  Antonin Bukovsky; Michael R Caudle; Marta Svetlikova; Nirmala B Upadhyaya
Journal:  Reprod Biol Endocrinol       Date:  2004-04-28       Impact factor: 5.211

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.